| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | BluePoint Laboratories | Sun Pharmaceutical Industries Limited | 20260521 | 5 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | Pfizer Laboratories Div Pfizer Inc | 20260505 | 28 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | 20260430 | 14 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | NorthStar RxLLC | Sun Pharmaceutical Industries Limited | 20260410 | 8 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20260406 | 24 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | BluePoint Laboratories | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited | 20260327 | 1 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited | 20260317 | 5 |
| These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous use Initial U.S. Approval: 1995 | Baxter Healthcare Corporation | Eurofins Biolab Srl | 20260310 | 5 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE LIPOSOME injection, for intravenous use Initial U.S. Approval: 1995 | Sagent Pharmaceuticals | 20260224 | 1 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | Lupin Pharmaceuticals, Inc. | 20251130 | 4 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | Dr. Reddy's Laboratories Inc. | Alembic Pharmaceuticals Limited | 20251129 | 1 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | Sagent Pharmaceuticals | 20250701 | 14 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20250701 | 4 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | Alembic Pharmaceuticals Limited | 20250701 | 1 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | Pfizer Laboratories Div Pfizer Inc | 20250331 | 1 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | BluePoint Laboratories | Fordoz Pharma Corporation | 20241211 | 1 |
| Doxorubicin Hydrochloride Injection USP | Fresenius Kabi USA, LLC | 20241014 | 5 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | Gland Pharma Limited | 20240924 | 12 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE INJECTION. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974 | Actavis Pharma, Inc. | 20240701 | 16 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE FOR INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE FOR INJECTION. DOXORUBICIN HYDROCHLORIDE for injection, for intravenous use Initial U.S. Approval: 1974 | Amneal Pharmaceuticals LLC | 20240529 | 12 |
| These highlights do not include all the information needed to use DOXOrubicin HCl safely and effectively. See full prescribing information for Doxorubicin HCl . DOXOrubicin HCl Injection, USP, for intravenous use Initial U.S. Approval: 1974 | Hikma Pharmaceuticals USA Inc. | 20240426 | 4 |
| These highlights do not include all the information needed to use DOXOrubicin HCl safely and effectively. See full prescribing information for DOXOrubicin HCl. DOXOrubicin HCl for Injection, USP, for intravenous use Initial U.S. Approval: 1974 | Hikma Pharmaceuticals USA Inc. | 20240426 | 3 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADRIAMYCIN (DOXOrubicin HCl) FOR INJECTION safely and effectively. See full prescribing information for ADRIAMYCIN (DOXOrubicin HCl) FOR INJECTION . ADRIAMYCIN (DOXOrubicin HCl) for Injection, USP, for intravenous use Initial U.S. Approval: 1974 | Hikma Pharmaceuticals USA Inc. | 20240411 | 7 |
| These highlights do not include all the information needed to use ADRIAMYCIN (DOXOrubicin HCl) safely and effectively. See full prescribing information for ADRIAMYCIN ( Doxorubicin HCl) . ADRIAMYCIN (DOXOrubicin HCl) Injection, USP, for intravenous use Initial U.S. Approval: 1974 | Hikma Pharmaceuticals USA Inc. | 20240411 | 10 |
| These highlights do not include all the information needed to use ADRIAMYCIN (DOXOrubicin HCl) safely and effectively. See full prescribing information for ADRIAMYCIN ( Doxorubicin HCl) . ADRIAMYCIN (DOXOrubicin HCl) Injection, USP, for intravenous use Initial U.S. Approval: 1974 | Hikma Pharmaceuticals USA Inc. | 20240411 | 3 |
| These highlights do not include all the information needed to use DOXOrubicin HCl safely and effectively. See full prescribing information for Doxorubicin HCl . DOXOrubicin HCl Injection, USP, for intravenous use Initial U.S. Approval: 1974 | Hikma Pharmaceuticals USA Inc. | 20240116 | 3 |
| Doxorubicin Hydrochloride Liposome Injection | Baxter Healthcare Corporation | 20231219 | 3 |
| DOXOrubicin Hydrochloride Liposome Injection | Zydus Lifesciences Limited | 20221101 | 2 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION DOXORUBICIN HYDROCHLORIDELIPOSOME INJECTION for intravenous infusion Initial U.S. Approval: 1995 | BluePoint Laboratories | Dr. Reddy’s Laboratories Limited | Natco Pharma Ltd | 20220928 | 4 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION . DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | NorthStar RxLLC | Dr. Reddy's Laboratories Limited | Natco Pharma Ltd | 20220901 | 6 |
| These highlights do not include all the information needed to use Doxorubicin hydrochloride for injection, USP safely and effectively. See full prescribing information for Doxorubicin hydrochloride for injection, USP. DOXORUBICIN hydrochloride for injection, USP for intravenous use Initial U.S. Approval: 1974 | Mylan Institutional LLC | 20220701 | 6 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information forDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995 | Dr. Reddy's Laboratories Inc | Natco Pharma Ltd | 20220701 | 9 |
| These highlights do not include all the information needed to use DOXIL safely and effectively. See full prescribing information for DOXIL. DOXIL (doxorubicin hydrochloride liposome injection), for intravenous use Initial U.S. Approval: 1995 | Baxter Healthcare Company | 20220531 | 13 |
| These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride liposome injection. Doxorubicin Hydrochloride Liposome Injection, for intravenous use Initial U.S. Approval: 1995 | Baxter Healthcare Company | 20220531 | 10 |
| These highlights do not include all the information needed to use doxorubicin hydrochloride safely and effectively. See full prescribing information for doxorubicin hydrochloride injection. DOXORUBICIN hydrochloride injection, USP for intravenous use Initial U.S. Approval: 1974 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20220117 | 5 |